Eagle Pharmaceuticals, Inc.
DANTROLENE FORMULATIONS AND METHODS OF THEIR USE
Last updated:
Abstract:
The disclosure is directed to liquid formulations of dantrolene, or a pharmaceutically acceptable salt thereof, and methods of their use in the treatment of disease.
Status:
Application
Type:
Utility
Filling date:
21 May 2019
Issue date:
5 Aug 2021